Safety and Efficacy of Yttrium-90-Labeled Anti-CD45 Antibody (Y-90-DOTA-BC8) Followed By a Standard Reduced-Intensity Hematopoietic Stem Cell Transplant (HCT) Regimen for Patients with Refractory/Relapsed Leukemia or High-Risk Myelodysplastic Syndrome (MDS)

著录项

• 来源
  《Blood: The Journal of the American Society of Hematology》 |2018年第novaelatreatmentappr期|共3页
• 作者

  Vo Phuong T.; Gooley Ted; Rajendran Joseph G.; Fisher Darrell R.; Orozco Johnnie J.; Green Damian J.; Gopal Ajay K.; Haaf Robyn; Nartea Margaret E.; Storb Rainer F.; Appelbaum Frederick R.; Press Oliver W.; Pagel John M.; Sandmaier Brenda M.;

  展开▼
• 作者单位

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Univ Washington Dept Nucl Med Seattle WA 98195 USA;

  Versant Med Phys &

  Radiat Dosimetry Richland WA USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Univ Washington Dept Med Seattle WA USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  Swedish Med Ctr Seattle WA USA;

  Fred Hutchinson Canc Res Ctr Div Clin Res 1124 Columbia St Seattle WA 98104 USA;

  展开▼
• 收录信息
• 原文格式 PDF
• 正文语种 eng
• 中图分类 血液及淋巴系疾病;
• 关键词